Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prostate Reirradiation Toxicity Outcomes Feasibility Study
Sponsor: University of Leeds
Summary
The RO-PIP trial aims to determine the feasibility of recruitment to a trial randomising patients to salvage ultra-hypofractionated external beam radiotherapy or high dose rate brachytherapy and provide prospective data on patient recorded toxicity outcomes that will inform a future phase III trial.
Official title: Reirradiation Options for Previously Irradiated Prostate Cancer (RO-PIP): Feasibility Randomised Clinical Trial Investigating Toxicity Outcomes Following Reirradiation With Ultra-hypofractionated External Beam Radiotherapy vs. High Dose Rate Brachytherapy
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2022-11-15
Completion Date
2026-11-15
Last Updated
2022-11-15
Healthy Volunteers
No
Conditions
Interventions
Brachytherapy
High Dose-Rate Brachytherapy
Sterotactic Body Radiotherapy
Hypofractionated External Beam Radiotherapy